跳至主要内容
临床试验/NCT01325922
NCT01325922已完成不适用

50/50% Tilt and Tune Defibrillation Waveforms Utilizing High Voltage Lead Integrity Check Impedance

Abbott Medical Devices0 个研究点开始时间: 2005年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成

研究概览

简要总结

Study Description The purpose of this study is to compare the defibrillation efficacy between the 50/50% tilt biphasic waveform and the Tuned biphasic waveform utilizing High Voltage Lead Integrity Check (HVLIC) impedance.

Hypothesis The Tuned waveform reduces defibrillation thresholds (DFTs) when compared to the 50/50% tilt waveform.

Study Methods

  • This is an acute, paired-sample, randomized (waveform testing sequence) study
  • Patients are implanted with an Food and Drug Administration (FDA) approved St. Jude Medical (SJM) EpicTM+ DR/VR Implantable Cardioverter Defibrillator (or any other standard output ICD after Epic+) and defibrillation lead system.
  • All study testing is completed at implant.
  • Patients are randomized to begin DFT testing with either the 50/50% tilt or Tuned waveform.
  • The HVLIC feature is used to measure the high voltage lead impedance and to program the Tuned and 50/50% tilt waveform pulse widths.
  • The DFT is determined by an optimized binary search method that is designed to reduce the overall number of VF inductions to an average of 5.13 while maintaining very high resolution and accuracy.
  • Total # of centers - 15 centers
  • Sample size - 60 patients

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient is a candidate for ICD implantation.
  • Patient is able to tolerate DFT testing.

排除标准

  • Patient has a mechanical valve in the tricuspid position.
  • Patient is pregnant.
  • Patient is less than 18 years old.

研究组 & 干预措施

50/50% Tilt

Other

干预措施: DFT Testing with a 50/50% tilt (Procedure)

研究者

申办方类型
Industry

相似试验